GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0653 $0.257 Monday, 22nd Apr 2024 JAGX stock ended at $0.180. This is 14.66% more than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 23.35% from a day low at $0.161 to a day high of $0.199.
90 days $0.0519 $0.257
52 weeks $0.0519 $1.22

Historical Jaguar Health, Inc. prices

Date Open High Low Close Volume
Apr 22, 2024 $0.167 $0.199 $0.161 $0.180 90 561 892
Apr 19, 2024 $0.162 $0.172 $0.154 $0.157 30 051 009
Apr 18, 2024 $0.144 $0.185 $0.142 $0.177 68 325 514
Apr 17, 2024 $0.185 $0.208 $0.150 $0.165 131 679 804
Apr 16, 2024 $0.104 $0.257 $0.104 $0.178 598 061 500
Apr 15, 2024 $0.102 $0.138 $0.100 $0.119 113 572 916
Apr 12, 2024 $0.109 $0.109 $0.0902 $0.0903 26 012 895
Apr 11, 2024 $0.111 $0.118 $0.101 $0.108 27 988 567
Apr 10, 2024 $0.125 $0.133 $0.101 $0.116 171 399 038
Apr 09, 2024 $0.0803 $0.0958 $0.0801 $0.0900 39 056 844
Apr 08, 2024 $0.0900 $0.0910 $0.0788 $0.0820 36 139 168
Apr 05, 2024 $0.0800 $0.0884 $0.0780 $0.0840 22 684 976
Apr 04, 2024 $0.0790 $0.0849 $0.0750 $0.0774 32 232 593
Apr 03, 2024 $0.0740 $0.0789 $0.0719 $0.0741 25 424 093
Apr 02, 2024 $0.0734 $0.0740 $0.0710 $0.0740 21 974 107
Apr 01, 2024 $0.0836 $0.0900 $0.0710 $0.0770 71 627 053
Mar 28, 2024 $0.0725 $0.0899 $0.0713 $0.0899 58 419 701
Mar 27, 2024 $0.0710 $0.0739 $0.0688 $0.0729 29 143 623
Mar 26, 2024 $0.0728 $0.0730 $0.0653 $0.0690 41 435 870
Mar 25, 2024 $0.0756 $0.0825 $0.0721 $0.0722 32 468 260
Mar 22, 2024 $0.0800 $0.0802 $0.0700 $0.0719 50 821 768
Mar 21, 2024 $0.0841 $0.0898 $0.0770 $0.0790 88 456 880
Mar 20, 2024 $0.0990 $0.0999 $0.0731 $0.0799 189 266 361
Mar 19, 2024 $0.0700 $0.0731 $0.0656 $0.0689 20 316 529
Mar 18, 2024 $0.0732 $0.0735 $0.0662 $0.0694 19 960 978
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT